Healthcare - Medical - Devices - NASDAQ - US
$ 70.98
0 %
$ 3.63 B
Market Cap
-709.8
P/E
BALANCE SHEET
720 M
ASSETS
82.4 M
LIABILITIES
638 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Axonics, Inc.
| Current Assets | 491 M |
| Cash & Short-Term Investments | 345 M |
| Receivables | 57.2 M |
| Other Current Assets | 89.2 M |
| Non-Current Assets | 229 M |
| Long-Term Investments | 0 |
| PP&E | 33.3 M |
| Other Non-Current Assets | 195 M |
| Current Liabilities | 45.8 M |
| Accounts Payable | 18.5 M |
| Short-Term Debt | 3.55 M |
| Other Current Liabilities | 23.8 M |
| Non-Current Liabilities | 36.5 M |
| Long-Term Debt | 25.8 M |
| Other Non-Current Liabilities | 10.7 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 104.8 | 238.8 | 220.9 | 241.2 | 171.1 | 98.3 | 24.4 | 8.2 |
| Short Term Investments | 240.1 | 118.4 | 0 | 0 | 12.6 | 59.2 | 0 | 0 |
| Receivables | 57.2 | 44.8 | 29.0 | 18.3 | 7.9 | 0.4 | 0 | 0 |
| Inventory | 79.9 | 55.8 | 64.9 | 63.1 | 15.7 | 3.7 | 1.5 | 0 |
| Other Current Assets | 9.3 | 7.3 | 12.9 | 10.9 | 8.9 | 6.8 | 0.5 | 0.5 |
| Total Current Assets | 491.4 | 465.1 | 321.3 | 327.9 | 211.7 | 165.3 | 26.9 | 8.7 |
| PP&E | 33.3 | 6.8 | 6.9 | 6.3 | 3.0 | 2.8 | 1.5 | 1.2 |
| Intangible Assets | 81.4 | 86.3 | 106.5 | 0.2 | 0.3 | 0.4 | 0.5 | 0.7 |
| Goodwill | 99.4 | 94.4 | 105.5 | 0 | 0 | 0 | 313 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1.8 | 1.2 |
| Other Long Term Assets | 14.4 | 6.8 | 7.7 | 7.7 | 4.8 | 3.4 | 0.4 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 719.9 | 659.4 | 547.9 | 342.2 | 219.8 | 171.9 | 29.4 | 10.9 |
| LIABILITIES | ||||||||
| Accounts Payable | 18.5 | 9.1 | 7.7 | 10.7 | 5.9 | 3.4 | 1.6 | 0.6 |
| Short Term Debt | 3.6 | 3.1 | 2.7 | 23.7 | 1.2 | 1.5 | 0 | 0 |
| Other Current Liabilities | 23.8 | 53.1 | 16.5 | 11.4 | 4.9 | 0.9 | 0.8 | 0.9 |
| Total Current Liabilities | 45.8 | 65.2 | 26.9 | 45.7 | 12.0 | 5.9 | 2.4 | 1.5 |
| Long Term Debt | 25.8 | 7.6 | 9.1 | 9.2 | 24.8 | 22.7 | 0.1 | 0.3 |
| Deferred Tax Income | 10.7 | 16.4 | 19.2 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 10.4 | 0 | 0 | 0 | 62.2 | 45.4 |
| Total Liabilities | 82.4 | 89.2 | 65.5 | 54.8 | 36.8 | 28.6 | 64.8 | 47.1 |
| EQUITY | ||||||||
| Common Stock | 5 K | 5 K | 5 K | 4 K | 3 K | 3 K | 278 | 233 |
| Retained Earnings | (380.4) | (374.3) | (314.6) | (234.5) | (179.6) | (99.6) | (67.2) | (49.1) |
| Other Accumulative Comprehensive Income/Loss | (15.9) | (25.1) | (6.6) | (0.4) | (0.4) | (0.4) | (0.4) | (1.0) |
| Total Equity | 637.6 | 570.1 | 482.4 | 287.4 | 183.0 | 143.3 | (35.4) | (36.3) |
| Total Liabilities and Equity | 719.9 | 659.4 | 547.9 | 342.2 | 219.8 | 171.9 | 29.4 | 10.9 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 49.1 | 46.7 | 43.1 | 37.0 | 28.6 | 7.0 | 18.6 | 18.4 |